-1- AIT (VP-SEC) 012E/2021 May 6, 2021 Subject: Management's Discussion and Analysis of Operating Results for Q1-2021 To: The President of the Stock Exchange of Thailand Summary of Operations Q1–2021
Microsoft Word - 2020-Q1_MDA_Eng_R0.docx No. CAZ 010-2020 11 May 2020 Subject: Management Discussion and Analysis for the 1st Quarter ended 31 March 2020 Attention: The President, The Stock
1 RP-AC 003/2020 AUGUST 14, 2020 Subject: Clarification of the operating results for the second quarter of 2020 To: Directors and Managers of the Stock Exchange of Thailand Richy Place 2002 Public
November 11, 2020 Subject: Management’s Discussion and Analysis for the third quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
-1- AIT (VP-SEC) 012E/2021 May 6, 2021 Subject: Management's Discussion and Analysis of Operating Results for Q1-2021 To: The President of the Stock Exchange of Thailand Summary of Operations Q1–2021
10th May, 2018 Subject: Management Discussion and Analysis (MD&A) of the financial as at and for three months’ period ending 31st March, 2018 Attention: President The Stock Exchange of Thailand P.C.S
(Translation) NEP-AC 001/2561 10 May 2018 Subject : Management Discussion and Analysis for 1st Quarter ended March 31, 2018 To : The President The Stock Exchange of Thailand Operating Result NEP
73 1 / 4 Ref. MD 016/2018 10th May 2018. Subj Management Discussion and Analysis (MD&A) Q1/2018 Dear Managing Director of Stock Exchange of Thailand We, Patum Rice Mill and Granary Public Company
. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public
and Analysis for Year Ending December 31, 2018 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 1/2019